cilomilast has been researched along with clavulanic acid in 3 studies
Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (clavulanic acid) | Trials (clavulanic acid) | Recent Studies (post-2010) (clavulanic acid) |
---|---|---|---|---|---|
162 | 13 | 42 | 1,801 | 212 | 424 |
Protein | Taxonomy | cilomilast (IC50) | clavulanic acid (IC50) |
---|---|---|---|
Beta-lactamase | Klebsiella pneumoniae | 1.72 | |
Beta-lactamase | Escherichia coli | 0.07 | |
Beta-lactamase | Citrobacter gillenii | 0.009 | |
Beta-lactamase | Shouchella clausii | 0.085 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Staphylococcus aureus | 0.08 | |
Beta-lactamase | Escherichia coli K-12 | 0.015 | |
Beta-lactamase SHV-1 | Escherichia coli | 0.028 | |
Beta-lactamase SHV-1 | Klebsiella pneumoniae | 0.17 | |
Beta-lactamase OXA-1 | Escherichia coli | 3.2 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 0.17 | |
Beta-lactamase | Pseudomonas aeruginosa PAO1 | 0.8 | |
Beta-lactamase TEM | Escherichia coli | 0.0933 | |
Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | 0.01 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Klebsiella pneumoniae | 0.02 | |
Class D beta-lactamase | Brachyspira pilosicoli | 2 | |
Beta-lactamase | Pseudomonas luteola | 0.036 | |
Beta-lactamase | Escherichia coli | 8.6 | |
Beta-lactamase | Escherichia coli | 0.009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
3 other study(ies) available for cilomilast and clavulanic acid
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |